Concepedia

Miguel Burgos

MB

Statistics

Publications

19

Citations

686

H-Index

17

Active since

2007

Affiliations

University of Castilla-La Mancha(Current)

Hospital General Universitario de Albacete

Centro de Investigación Biomédica en Red de Cáncer

Hospital Clínico San Carlos

Centro de Investigación del Cáncer

Miguel Burgos is an author at University of Castilla-La Mancha specializing in oncology, life sciences, and molecular oncology.

ORCID

Publications per year

2007–2022

19

Publications

19

Activity of BET-proteolysis targeting chimeric (PROTAC) compounds in triple negative breast cancer

María del Mar Noblejas‐López, Cristina Nieto‐Jiménez, Miguel Burgos et al. · Journal of Experimental & Clinical Cancer Research · 2019 · 104 citations · Full text

, , +13

Synthetic Lethality Interaction Between Aurora Kinases and CHEK1 Inhibitors in Ovarian Cancer

Ana Alcaráz-Sanabria, Cristina Nieto‐Jiménez, Verónica Corrales‐Sánchez et al. · Molecular Cancer Therapeutics · 2017 · 63 citations · Full text

, , +17

Trastuzumab-Targeted Biodegradable Nanoparticles for Enhanced Delivery of Dasatinib in HER2+ Metastasic Breast Cancer

Enrique Niza, María del Mar Noblejas‐López, Iván Bravo et al. · Nanomaterials · 2019 · 61 citations · Full text

, , +17

CD5 expression promotes IL-10 production through activation of the MAPK/Erk pathway and upregulation of TRPC1 channels in B lymphocytes

Soizic Garaud, Taher E. Taher, Marjolaine Debant et al. · Cellular and Molecular Immunology · 2016 · 54 citations · Full text

, , +10

Glitazones Induce Astroglioma Cell Death by Releasing Reactive Oxygen Species from Mitochondria: Modulation of Cytotoxicity by Nitric Oxide

José Manuel Pérez‐Ortiz, Pedro Tranque, Miguel Burgos et al. · Molecular Pharmacology · 2007 · 50 citations

, , +17

1–5 of 19